Use of sphingosine-1-phosphate (S1P) receptor agonists in combination with a second agent for the treatment of brain degenerative diseases
作者： Nicole Kaneider , Volker Brinkmann , Christian J. Wiedermann
DOI:
关键词:
摘要: Disclosed is a new use for sphingosine-1-phosphate (S1P) receptor agonists in combination with second agent, preferably selected from an AMPA agonist, nootropic painkiller and anti-inflammatory agent the treatment of progressive dementia or brain degenerative diseases.
lens.org 参考文章(22)
Martin H. Levinson, The Merck Manual of Diagnosis and Therapy, 17th Edition et Cetera. ,vol. 57, pp. 117- ,(2000)
Kenji Chiba, Kunitomo Adachi, Compositions and methods of using compositions with accelerated lymphocyte homing immunosuppressive properties ,(2003)
Vincenzo Casolaro, Gianni Marone, Vincenzo Patella, Giuseppe Spadaro, In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils. Journal of Immunology. ,vol. 151, pp. 5563- 5573 ,(1993)
Peter Buehlmayer, Carsten Spanka, Klaus Hinterding, Frédéric Zecri, Amino-propanol derivatives ,(2003)
Gilles Feutren, Robert Paul Hof, Volker Brinkmann, Use of S1P Receptor Agonists in Heart Diseases ,(2003)
Ji-Hye Paik, Teresa Sanchez, Kevin P. Claffey, Timothy Hla, Methods of inhibiting vascular permeability and apoptosis ,(2004)
Paul William Glue, Peter C. Hiestand, Carolyn Ann Foster, Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders ,(2003)
George A. Doherty, William E. Neway, Jeffrey J. Hale, Christopher L. Lynch, Sander G. Mills, Amy Gentry, Robert L. Bugianesi, Edg receptor agonists ,(2003)
Per Lindquist, Treatment of disorders of nervous systemsystem with fty720 ,(2004)